US Broker Ratings

Pharvaris N.V. (PHVS) Stock Analysis: A 102.97% Potential Upside You Can’t Ignore

Pharvaris N.V. (PHVS), a pioneering player in the biotechnology sector, has caught the eye of investors with its promising pipeline and substantial growth potential. With a..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating a 25.52% Upside Potential Amidst Market Challenges

Fortrea Holdings Inc. (NASDAQ: FTRE), a contract research organization based in Durham, North Carolina, has positioned itself as a key player in the healthcare sector, specifically..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Biotechnology’s Next Big Player with 194.72% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a burgeoning name in the biotechnology sector, is capturing investor interest with its trailblazing approach to autoimmune and inflammatory disease treatments...

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: A Promising 229% Upside Potential for Investors

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, is capturing investor attention with its significant potential upside, estimated at 229.35%. Specializing..

Akebia Therapeutics, Inc. (AKBA): Unveiling a 107% Potential Upside and Analyst Confidence

Investors looking for promising opportunities in the healthcare sector might find Akebia Therapeutics, Inc. (NASDAQ: AKBA) an intriguing candidate. With a robust market capitalization of $934.98..

Relay Therapeutics, Inc. (RLAY): Analyst Ratings Signal a 313.69% Upside Potential for Investors

Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company based in Cambridge, Massachusetts, is gaining attention in the healthcare sector for its innovative approach to drug..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Unveiling a 115% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is capturing investor attention with its promising upside potential. As a clinical-stage biotechnology company, Amylyx is dedicated to pioneering treatments for..

Septerna, Inc. (SEPN) Stock Analysis: Exploring a Potential 125% Upside in the Biotech Sector

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology firm, is attracting attention in the healthcare sector with its promising pipeline and significant potential upside for investors. Though..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: A Biotech Play with 245% Potential Upside

Mind Medicine (MindMed) Inc. (MNMD) has recently caught the attention of investors due to its impressive potential upside of 245.56%, making it a compelling option in..

Savara, Inc. (SVRA) Stock Analysis: Strong Buy Ratings Highlight 241% Upside Potential

Investors in the biotechnology sector, particularly those with a focus on rare diseases, may find Savara, Inc. (NASDAQ: SVRA) an intriguing prospect. With a market capitalization..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 78.18% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a burgeoning player in the healthcare sector, operates within the medical devices industry, focusing on innovative solutions for bunion and..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Innovator with Significant Revenue Growth and Strategic Expansion

LifeMD, Inc. (LFMD) is making waves in the healthcare sector with its innovative approach to telehealth services. As a direct-to-patient telehealth company, LifeMD connects consumers with..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: High Growth and Strategic Positioning in the Bioscience Market

Niagen Bioscience, Inc. (NAGE) is gaining attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.09 billion, this U.S.-based company..

Orthofix Medical Inc. (OFIX) Investor Outlook: Assessing the 135.75% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX) is carving a niche in the healthcare sector, particularly in the medical devices industry. With its strategic focus on innovative solutions..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a Potential 244% Upside Despite Challenges

Tilray Brands, Inc. (NASDAQ: TLRY) has emerged as a notable player in the healthcare sector, focusing on specialty and generic drug manufacturing. Despite the challenges inherent..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a 92% Potential Upside in the Biotech Arena

Oculis Holding AG (NASDAQ: OCS), a Swiss biopharmaceutical company, is capturing investor attention with its strong growth potential in the healthcare sector. Specializing in cutting-edge ophthalmic..

KalVista Pharmaceuticals, Inc. (KALV): Investor Outlook Reveals 114.82% Potential Upside in Biotechnology Sector

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and remarkable potential upside. Headquartered in..

Xencor, Inc. (XNCR) Stock Analysis: Unpacking the 237% Potential Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its significant 237% potential upside. Operating within the dynamic biotechnology sector, Xencor is..

Butterfly Network, Inc. (BFLY) Stock Analysis: A 92.90% Upside Potential in the Healthcare Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the healthcare sector specializing in medical devices, has recently captured investor attention with a staggering potential upside..

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Exploring a 60% Potential Upside

Theravance Biopharma, Inc. (NASDAQ: TBPH), a company nestled within the dynamic biotechnology sector, presents an intriguing opportunity for investors with its significant potential upside. With a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds